NDC 82922-030 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-030
- Package NDCs from labels
- 82922-030-02
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TERBUTALINE SULFATE - Truemed Group LLC | Truemed Group LLC | 2022-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terbutaline Sulfate | TERBUTALINE SULFATE | Chartwell RX, LLC. | 859267c6-3d14-4123-9b9d-4fc248f09726 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Upsher-Smith Laboratories, LLC | 3a4e5046-293c-4616-8679-6da65f31626b | 2025-08-27 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| TERBUTALINE SULFATE | TERBUTALINE SULFATE | Amneal Pharmaceuticals of New York LLC | 382dcebb-6e41-4335-818d-b5822e3fb884 | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Henry Schein, Inc. | 9f4b177e-4d7d-4255-afeb-522c7d4594c6 | 2025-07-16 | Warnings, Adverse reactions | 576PU70Y8E |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Hikma Pharmaceuticals USA Inc. | 613df3cb-4d55-4d12-ab08-a932481aaa0b | 2024-01-04 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Medical Purchasing Solutions. LLC | 6a22b62c-4ee1-49df-e053-2a91aa0a3e52 | 2023-05-23 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| ed8b5555-7104-651c-e053-2a95a90af4b9 | e5f7e7de-1791-0d1a-e053-2a95a90a6ead | 2022-11-15 | e5f7e7de-1791-0d1a-e053-2a95a90a6ead | |||
| Terbutaline Sulfate | TERBUTALINE SULFATE | Fresenius Kabi USA, LLC | cec31032-f366-4524-9e01-63146e473b2b | 2022-07-12 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Proficient Rx LP | 0a95bc4f-34d3-4b5e-841b-6839e1c1e0c7 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Lannett Company, Inc. | fbf54709-5857-4dbc-9233-ebd7abff88c8 | 2020-11-12 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| Terbutaline Sulfate | TERBUTALINE SULFATE | Hikma Pharmaceuticals USA Inc. | 0f4d3249-e022-40b6-b93d-f605e8522207 | 2020-10-01 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
| Terbutaline Sulfate | TERBUTALINE SULFATE | ANI Pharmaceuticals, Inc. | d810a15b-3e10-4f6c-a36e-8ddecbaba9c3 | 2019-11-15 | Boxed warning, Warnings, Adverse reactions | 576PU70Y8E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.